Why Spark and Watchdog ICER Don’t See Eye-to-Eye on $850K Gene Therapy – Xconomy
|
Why Spark and Watchdog ICER Don't See Eye-to-Eye on $850K Gene Therapy
Xconomy The first gene therapy approved in the U.S. costs $850,000. Announcing the price on Jan. 3, its owner Spark Therapeutics held out the possibility of some relief, such as installment payments, or slim rebates if the drug, a one-time shot into each eye … |
